This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatuur
Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003;60(12):1909-15.
Bouwman FH, Schoonenboom SN, Flier WM van der, et al. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging. 2007;28(7):1070-4.
Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389-404.
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239-59.
Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging 1997;18:S1–2.
Flier WM van der, Schoonenboom SN, Pijnenburg YA, et al. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology. 2006;67(3):526-7.
Flier WM van der, Staekenborg S, Pijnenburg YA, et al. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 2007;23:42-6.
Hsiung GYR, Sadovnick AD. Genetics and dementia: riskfactors, diagnosis and management. Alzheimers Dement. 2007;3:418-27.
Kivipelto M, Ngandu T, Laatikainen T, et al. Riskscore for prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006;5:735-41.
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306-19.
Kwaliteitsinstituut voor de gezondheidszorg CBO. Richtlijn Diagnostiek en medicamenteuze behandeling van dementie. 2005. www.cbo.nl.
Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J Neurol. 2006;253:139-58.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34(7):939-44.
Patterson C, et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ. 2008;178:548-56.
Piscopo P, Marcon G, Piras MR et al. A novel PSEN2 mutation associated with a peculiar phenotype. Neurology. 2008;70:1549-54.
Raina P, Santaguida P, Ismaila A, et al. Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. Ann Intern Med. 2008;148: 379-97.
Scheltens P, Fox N, Barkhof F, et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1(1):13-21.
Waring SC, Rosenberg RN. Genome-wide association studies in Alzheimer disease. Arch Neurol. 2008;65:329-34.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij
About this chapter
Cite this chapter
Scheltens, P., van der Flier, W., Rozemuller, A., Pijnenburg, Y. (2009). 18 Ziekte van Alzheimer. In: Jonker, C., Slaets, J., Verhey, F. (eds) Handboek dementie. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8061-9_18
Download citation
DOI: https://doi.org/10.1007/978-90-313-8061-9_18
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-6228-8
Online ISBN: 978-90-313-8061-9
eBook Packages: Dutch language eBook collection